Cargando…

Commentary: Inhibitors of mitochondrial respiratory chain in the treatment of type 2 diabetes

Detalles Bibliográficos
Autor principal: Ye, Jianping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326288/
https://www.ncbi.nlm.nih.gov/pubmed/37425063
http://dx.doi.org/10.1016/j.apsb.2023.03.016
_version_ 1785069392670752768
author Ye, Jianping
author_facet Ye, Jianping
author_sort Ye, Jianping
collection PubMed
description
format Online
Article
Text
id pubmed-10326288
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-103262882023-07-08 Commentary: Inhibitors of mitochondrial respiratory chain in the treatment of type 2 diabetes Ye, Jianping Acta Pharm Sin B Commentary Elsevier 2023-06 2023-03-21 /pmc/articles/PMC10326288/ /pubmed/37425063 http://dx.doi.org/10.1016/j.apsb.2023.03.016 Text en © 2023 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Commentary
Ye, Jianping
Commentary: Inhibitors of mitochondrial respiratory chain in the treatment of type 2 diabetes
title Commentary: Inhibitors of mitochondrial respiratory chain in the treatment of type 2 diabetes
title_full Commentary: Inhibitors of mitochondrial respiratory chain in the treatment of type 2 diabetes
title_fullStr Commentary: Inhibitors of mitochondrial respiratory chain in the treatment of type 2 diabetes
title_full_unstemmed Commentary: Inhibitors of mitochondrial respiratory chain in the treatment of type 2 diabetes
title_short Commentary: Inhibitors of mitochondrial respiratory chain in the treatment of type 2 diabetes
title_sort commentary: inhibitors of mitochondrial respiratory chain in the treatment of type 2 diabetes
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326288/
https://www.ncbi.nlm.nih.gov/pubmed/37425063
http://dx.doi.org/10.1016/j.apsb.2023.03.016
work_keys_str_mv AT yejianping commentaryinhibitorsofmitochondrialrespiratorychaininthetreatmentoftype2diabetes